Study rethinks immune system strategies to boost vaccine effectiveness

A recent Cell journal review explores key immunological assumptions to enhance our understanding of vaccine design, autoimmune responses, and immune system pathology, aiming to refine intervention strategies and theoretical frameworks in immunology.

Pfizer brings Indian generics maker to court over Xeljanz patent

Pfizer filed suit against an Indian pharmaceutical company on Friday over its application to market generic versions of Xeljanz XR. Xeljanz XR is an extended

August 20, 2024

Pfizer targeted by activist, following post-pandemic stumbles — reports

The activist investor Starboard Value has taken a stake in Pfizer, according to media reports, following the drugmaker’s months of lackluster results as it came

October 8, 2024

FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLC

Ahead of a meeting of the Oncologic Drugs Advisory Committee on Thursday, FDA reviewers raised a host of concerns about the confirmatory trial data for

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.